Related Experiment Video
Updated: Mar 10, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Unveiling the link between insulin-like growth factor 1 (IGF-1) and fatty liver progression: From bench to bedside
Kornkanok Srimanus1, Alisara Damrongmanee1, Nuthapong Ukarapol1
1Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
Abstract:
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has been rising, but the pathogenesis remains elusive, and effective treatments are limited. Insulin growth factor-1 (IGF-1), part of the somatotropic pathway, has been associated with the development and progression of liver steatosis. Several clinical studies have reported a relationship between a decrease in IGF-1 and the progression of MASLD in both children and adults. Several in vivo, in vitro and ex-vivo studies have also proposed various insights into the mechanisms of IGF-1 on the development of MASLD. Furthermore, recent evidence suggests that interventions improving metabolic health may restore the suppressed GH-IGF-1 axis. In this review, existing evidence from clinical, in vivo, in vitro and ex-vivo studies regarding the roles of IGF-1 in MASLD pathogenesis is summarized. The IGF-1 levels could serve as a non-invasive biomarker for monitoring disease progression and therapeutic response. Any contradictory findings will be included and discussed.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
PI3K/mTOR/AKT Signaling Pathway
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Insulin Secretory Vesicles